Volufiline, a patented cosmetic ingredient developed by French company Sederma, has entered the skin-plumping market as a topical alternative to injectable fillers. The ingredient combines hydrogenated polyisobutene with an extract from Anemarrhena asphodeloides, a plant used in Asian medicine.
Dr. Deborah R. Spey, a board-certified dermatologist at Schweiger Dermatology in Livingston, New Jersey, explains that Volufiline is believed to encourage existing fat cells to store more lipids and support the maturation of new fat cells in deeper skin layers. "However, there is very limited scientific data supporting its effectiveness, and any reported plumping effects have been quite modest," Spey tells ELLE. "While the concept is promising, more research is needed to determine how effectively a topical formulation can deliver these results."
Beverly Hills esthetician Candace Marino describes the effects as subtle. "Think subtle improvement over time, not overnight change," she says.
Spey clarifies that Volufiline differs fundamentally from injectable dermal fillers, which are made from cross-linked hyaluronic acid and injected into specific tissue planes. "There is a significant difference between injectable fillers, which can reach deeper structural layers, and a topical product, which has limitations in how deeply it can penetrate the skin. Volufiline should not be considered a replacement for injectable dermal fillers, particularly for individuals seeking noticeable volume restoration," she explains.
Spey recommends Volufiline for individuals with mild volume loss but cautions that because it is oil-based, it may aggravate oily or acne-prone skin. The ingredient has not been adequately studied for use during pregnancy.
Volufiline pairs well with peptides, ceramides, squalane, hyaluronic acid, niacinamide, and growth factors. Spey advises against layering it directly with retinoids or strong exfoliating acids to minimize irritation.